Growth hormone enhances thymic function in HIV-1-infected adults

Journal of Clinical Investigation

Volumn 118, Issue 3, 2008, Pages 1085-1098

  Napolitano, Laura A ^a,b   Schmidt, Diane ^b   Gotway, Michael B ^b   Ameli, Niloufar ^b   Filbert, Erin L ^a   Ng, Myra M ^a   Clor, Julie L ^a   Epling, Lorrie ^b   Sinclair, Elizabeth ^b   Baum, Paul D ^b   Li, Kai ^a   Killian, Marisela Lua ^b   Bacchetti, Peter ^b   McCune, Joseph M ^b  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTHRALGIA; ARTICLE; CARPAL TUNNEL SYNDROME; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAPHORESIS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG WITHDRAWAL; EDEMA; FATIGUE; GLUCOSE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERAMYLASEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IMMUNE SYSTEM; INSOMNIA; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TENOSYNOVITIS; THYMUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CROSS-OVER STUDIES; GROWTH HORMONE; HIV-1; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHOPOIESIS; MIDDLE AGED; PROSPECTIVE STUDIES; THYMUS GLAND;

EID: 40549089870     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32830     Document Type: Article

References (58)

1. Connors, M., et al. 1997. HIV induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:533-540.
2. Teixeira, L., et al. 2001. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS. 15:1749-1756.
3. Lecossier, D., Bouchonnet, F., Schneider, P., Clavel, F., and Hance, A.J. 2001. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. J. Infect. Dis. 183:1009-1016.
4. Kaufmann, G.R., et al. 2002. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS. 16:359-367.
5. Kaufmann, G.R., et al. 2003. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch. Intern. Med. 163:2187-2195.
6. Gandhi, R.T., et al. 2006. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J. Acquir. Immune Defic. Syndr. 42:426-434.
7. Gea-Banacloche, J.C., et al. 2000. Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients. AIDS Res. Hum. Retroviruses. 16:1877-1886.
8. Komanduri, K.V., et al. 2001. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J. Infect. Dis. 183:1285-1289.
9. Gandhi, R.T., and Walker, B.D. 2002. Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection. Curr. Opin. Immunol. 14:487-494.
10. Klenerman, P., Wu, Y., and Phillips, R. 2002. HIV: current opinion in escapology. Curr. Opin. Microbiol. 5:408-413.
11. Douek, D.C., et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature. 396:690-695.
12. Poulin, J.-F., et al. 1999. Direct evidence for thymic function in adult humans. J. Exp. Med. 190:479-486.
13. Choyke, P.L., et al. 1987. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. AJR Am. J. Roentgenol. 149:269-272.
14. Kissin, C.M., Husband, J.E., Nicholas, D., and Eversman, W. 1987. Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology. 163:67-70.
15. McCune, J.M., et al. 1998. High prevalence of thymic tissue in adults with HIV-1 infection. J. Clin. Invest. 101:2301-2308.
16. Mackall, C.L., et al. 1995. Age, thymopoiesis and CD4+ T lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143.
17. Mackall, C.L., et al. 1997. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood. 89:3700-3707.
18. Smith, K.Y., et al. 2000. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J. Infect. Dis. 181:141-147.
19. Vigano, A., et al. 2000. Early immune reconstitution after potent antiretroviral therapy in HIV- infected children correlates with the increase in thymus volume. AIDS. 14:251-261.
20. Kalayjian, R.C., et al. 2005. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J. Infect. Dis. 192:1577-1587.
21. Kolte, L., et al. 2002. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 185:1578-1585.
22. Harris, J.M., et al. 2005. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin. Immunol. 115:138-146.
23. Hakim, F.T., et al. 2005. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115:930-939.
24. Clark, R. 1997. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr. Rev. 18:157-179.
25. Knyszynski, A., Adler-Kunin, S., and Globerson, A. 1992. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow. Brain Behav. Immun. 6:327-340.
26. Kelley, K.W., Arkins, S., Liu, Q., and Dantzer, R. 1996. Growth hormone, growth factors, and hematopoiesis. Horm. Res. 45:38-45.
27. Montecino-Rodriguez, E., Clark, R., and Dorshkind, K. 1998. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology. 139:4120-4126.
28. Murphy, W.J., Durum, S.K., and Longo, D.L. 1992. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc. Natl. Acad. Sci. U. S. A. 89:4481-4485.
29. Woo, J.C., Dean, G.A., Lavoy, A., Clark, R., and Moore, P.F. 1999. Investigation of recombinant human insulin-like growth factor type I in thymus regeneration in the acute stage of experimental FIV infection in juvenile cats. AIDS Res. Hum. Retroviruses. 15:1377-1388.
30. Lo, J.C., et al. 2001. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J. Clin. Endocrinol. Metab. 86:3480-3487.
31. Napolitano, L.A., et al. 2002. Increased thymic mass and circulating naive CD4 T cells in HIV-1- infected adults treated with growth hormone. AIDS. 16:1103-1111.
32. Rietschel, P., et al. 2001. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J. Clin. Endocrinol. Metab. 86:504-510.
33. Okumura, M., et al. 1993. Age-related accumulation of LFA-1 high cells in a CD8+CD45RA high T cell population. Eur. J. Immunol. 23:1057-1063.
34. Scala, E., et al. 1995. Expansion of CD11a bright cells in CD8+CD45RA+ from HIV-infected patients: a new early marker for disease progression? AIDS Res. Hum. Retroviruses. 11:1327-1333.
35. Hoflich, C., Docke, W.D., Busch, A., Kern, F., and Volk, H.D. 1998. CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cells. Int. Immunol. 10:1837-1845.
36. Olsen, N.J., and Kovacs, W.J. 2001. Effects of androgens on T and B lymphocyte development. Immunol. Res. 23:281-288.
37. Smith, K., et al. 2004. Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy. AIDS. 18:1953-1956.
38. McFarland, R.D., Douek, D.C., Koup, R.A., and Picker, L.J. 2000. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. U. S. A. 97:4215-4220.
39. De Rosa, S.C., Herzenberg, L.A., and Roederer, M. 2001. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7:245-248.
40. Antov, A., Yang, L., Vig, M., Baltimore, D., and Van Parijs, L. 2003. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:3435-3441.
41. Bernasconi, A., et al. 2006. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics. 118:e1584-e1592.
42. Kooijman, R., and Coppens, A. 2004. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J. Leukoc. Biol. 76:862-867.
43. Tian, Z.G., et al. 1998. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells. 16:193-199.
44. French, R.A., et al. 2002. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology. 143:690-699.
45. Carlo-Stella, C., et al. 2004. Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone. Exp. Hematol. 32:171-178.
46. Hanley, M.B., Napolitano, L.A., and McCune, J.M. 2005. Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells. 23:1170-1179.
47. Min, H., Montecino-Rodriguez, E., and Dorshkind, K. 2004. Reduction in the developmental potential of intrathymic T cell progenitors with age. J. Immunol. 173:245-250.
48. Sabharwal, P., and Varma, S. 1996. Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor. J. Clin. Endocrinol. Metab. 81:2663-2669.
49. Taub, D.D., et al. 1994. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J. Clin. Invest. 94:293-300.
50. Smaniotto, S., et al. 2004. Growth hormone stimulates the selective trafficking of thymic CD4+CD8-emigrants to peripheral lymphoid organs. Neuroimmunomodulation. 11:299-306.
51. Chu, Y.W., et al. 2004. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood. 104:1110-1119.
52. Ribeiro-Carvalho, M.M., et al. 2007. Triiodothyronine modulates differential homing of recent thymic emigrants to peripheral lymphoid organs. Scand. J. Immunol. 66:8-16.
53. Mulligan, K., Grunfeld, C., Hellerstein, M.K., Neese, R.A., and Schambelan, M. 1993. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 77:956-962.
54. Schambelan, M., et al. 1996. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann. Intern. Med. 125:873-882.
55. Engelson, E.S., et al. 2002. Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection. J. Acquir Immune Defic. Syndr. 30:379-391.
56. Moyle, G.J., et al. 2004. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J. Acquir Immune Defic. Syndr. 35:367-375.
57. Koutkia, P., Eaton, K., You, S.M., Breu, J., and Grinspoon, S. 2006. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution. AIDS. 20:855-862.
58. Dion, M.L., et al. 2004. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity. 21:757-768.